Capital Fund Management (CFM)
NVAX icon

Capital Fund Management (CFM)’s Novavax NVAX Stock Holding History

Capital Fund Management (CFM)’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-117,400
Closed -$740K – 2616
2025
Q2 		$740K Sell
117,400
-87,100
-43% -$577K ﹤0.01% 2100
2025
Q1 		$1.31M Buy
204,500
+4,000
+2% +$33.1K ﹤0.01% 1569
2024
Q4 		$1.61M Buy
200,500
+148,100
+283% +$1.43M ﹤0.01% 1587
2024
Q3 		$662K Buy
52,400
+17,200
+49% +$222K ﹤0.01% 1791
2024
Q2 		$446K Buy
+35,200
New +$354K ﹤0.01% 1778
2024
Q1 		– Sell
-154,700
Closed -$743K – 2197
2023
Q4 		$743K Sell
154,700
-7,900
-5% -$48.4K ﹤0.01% 1907
2023
Q3 		$1.18M Sell
162,600
-165,100
-50% -$1.32M ﹤0.01% 1589
2023
Q2 		$2.43M Sell
327,700
-137,400
-30% -$1.08M 0.01% 1117
2023
Q1 		$3.22M Sell
465,100
-230,500
-33% -$2.12M 0.02% 899
2022
Q4 		$7.15M Buy
695,600
+222,700
+47% +$3.93M 0.05% 511
2022
Q3 		$8.61M Buy
472,900
+304,200
+180% +$13.2M 0.07% 365
2022
Q2 		$8.68M Buy
168,700
+101,400
+151% +$5.25M 0.08% 347
2022
Q1 		$4.96M Buy
+67,300
New +$6M 0.04% 574
2021
Q4 		– Sell
-21,600
Closed -$4.48M – 1771
2021
Q3 		$4.48M Buy
21,600
+6,300
+41% +$1.39M 0.03% 622
2021
Q2 		$3.25M Buy
+15,300
New +$2.8M 0.03% 747

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Fund Management (CFM)'s NVAX Position: Q1 2025 in Review

Capital Fund Management (CFM) sold out of Novavax (NVAX) in Q1 2025, closing a stake of 287,804 shares — an estimated $2.38M sold.

Capital Fund Management (CFM) first reported a position in NVAX in Q4 2015 and held it in 8 quarters. The position peaked at $13.2M in Q2 2021. 246 funds tracked by Wall St. Rank hold NVAX as of Q1 2025.

  • Capital Fund Management (CFM) reported no remaining Novavax position as of Q1 2025 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 287,804 Novavax shares in Q1 2025, an estimated $2.38M.
  • Capital Fund Management (CFM) first reported a position in Novavax in Q4 2015 and held it in 8 quarters.
  • Capital Fund Management (CFM)'s Novavax position peaked at $13.2M in Q2 2021.
  • 246 funds tracked by Wall St. Rank held Novavax as of Q1 2025.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2025, filed 14 May 2025.